Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.8K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

10.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.9K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

6.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
Inflammation01:38

Inflammation

46.6K
Overview
46.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Strategy to Reduce >350 000 Yearly Deaths From Atherosclerotic Coronary Artery Disease by 2050 in the United States.

Circulation. Population health and outcomes·2026
Same author

Generation and characterization of two human induced pluripotent stem cell lines from young and older male donors.

Stem cell research·2025
Same author

Variability in State-Level Regulations Regarding Occupational Radiation Exposure.

Journal of the Society for Cardiovascular Angiography & Interventions·2025
Same author

Effect of Frailty on In-Hospital Mortality and Complications of PCI: An NCDR Registry Report.

Journal of the American College of Cardiology·2025
Same author

Challenges in diagnosing coronary microvascular dysfunction and coronary vasospasm.

Cardiovascular revascularization medicine : including molecular interventions·2025
Same author

The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma.

Lancet (London, England)·2025
Same journal

Overview of Novel Mechanisms in Obesity Pharmacotherapy and Implications for Cardiovascular Disease: A Narrative Review.

Current atherosclerosis reports·2026
Same journal

Artificial and Other Non-Nutritive Sweeteners, the Microbiome, and Cardiometabolic Health.

Current atherosclerosis reports·2026
Same journal

Single-cell Technologies in Atherosclerosis: Uncovering Cellular Heterogeneity, Mechanisms, and Therapeutic Opportunities.

Current atherosclerosis reports·2026
Same journal

Primary Prevention of Dyslipidemia: 10 Practice-Changing Takeaways from the 2026 ACC/AHA Multisociety Guideline.

Current atherosclerosis reports·2026
Same journal

Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.

Current atherosclerosis reports·2026
Same journal

Familial Hypercholesterolemia in Women: Diagnosis, Treatment, and Cardiovascular Outcomes Across the Lifespan.

Current atherosclerosis reports·2026
See all related articles

Related Experiment Video

Updated: Apr 29, 2026

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.6K

CD39: Interface between vascular thrombosis and inflammation.

Yogendra M Kanthi1, Nadia R Sutton, David J Pinsky

  • 1Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan Medical School, 1500 E. Medical Center Drive, SPC 5853, Suite 2141, Ann Arbor, MI, 48109-5853, USA, ykanthi@med.umich.edu.

Current Atherosclerosis Reports
|May 20, 2014
PubMed
Summary
This summary is machine-generated.

Extracellular nucleotides are key in vascular issues. CD39, an enzyme, regulates these nucleotides, impacting blood clotting and inflammation, offering therapeutic potential for diseases like stroke.

More Related Videos

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
11:18

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

15.0K
Intravital Microscopy of Leukocyte-endothelial and Platelet-leukocyte Interactions in Mesenterial Veins in Mice
05:12

Intravital Microscopy of Leukocyte-endothelial and Platelet-leukocyte Interactions in Mesenterial Veins in Mice

Published on: August 13, 2015

11.8K

Related Experiment Videos

Last Updated: Apr 29, 2026

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.6K
Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
11:18

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

15.0K
Intravital Microscopy of Leukocyte-endothelial and Platelet-leukocyte Interactions in Mesenterial Veins in Mice
05:12

Intravital Microscopy of Leukocyte-endothelial and Platelet-leukocyte Interactions in Mesenterial Veins in Mice

Published on: August 13, 2015

11.8K

Area of Science:

  • Vascular Biology
  • Immunology
  • Biochemistry

Background:

  • Extracellular nucleotides significantly influence vascular thrombosis and inflammation.
  • Dysregulated purinergic signaling contributes to platelet and leukocyte activation, and endothelial dysfunction.
  • CD39, a key vascular nucleotidase, hydrolyzes ATP and ADP to produce adenosine, an anti-inflammatory and antithrombotic mediator.

Purpose of the Study:

  • To highlight the central role of CD39 in the purinergic signaling pathway.
  • To underscore the importance of CD39 in maintaining vascular homeostasis and responding to injury.
  • To explore therapeutic strategies targeting CD39 for vascular thromboinflammatory diseases.

Main Methods:

  • Review of existing literature on purinergic signaling and CD39 function.
  • Analysis of the role of CD39 in platelet aggregation, endothelial activation, and leukocyte recruitment.
  • Examination of CD39's involvement in diseases such as stroke, ischemia-reperfusion injury, and pulmonary hypertension.

Main Results:

  • CD39 is a critical modulator of vascular thrombosis and inflammation.
  • The purinergic signaling system, centered on CD39, is vital for vascular homeostasis.
  • Alterations in extracellular nucleotide concentrations activate pro-thrombotic and pro-inflammatory pathways.

Conclusions:

  • CD39 plays a pivotal role in regulating vascular thromboinflammatory processes.
  • Targeting CD39 presents a promising therapeutic avenue for managing vascular diseases.
  • Understanding the purinergic system is crucial for developing novel treatments for vascular conditions.